Seeing Is Believing
Healthcare - Sector
SUPN is currently covered by 3 analysts with an average price target of $64.35. This is a potential upside of $13.18 (25.76%) from yesterday's end of day stock price of $51.17.
Supernus Pharmaceuticals's activity chart (see below) currently has 100 price targets and 74 ratings on display. The stock rating distribution of SUPN is 57.14% HOLD and 42.86% BUY.
Analysts average stock forecasts to be materialized ratio is 77.22% with an average time for these price targets to be met of 355 days.
Highest price target for SUPN is $65, Lowest price target is $55, average price target is $61.
Most recent stock forecast was given by ANNABEL SAMIMY from STIFEL on 19-Dec-2025. First documented stock forecast 12-Mar-2015.
Currently out of the existing stock ratings of SUPN, 4 are a HOLD (57.14%), 3 are a BUY (42.86%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 16-Apr-2020
$55
$5.53 (11.18%)
20 days ago
(19-Dec-2025)
6/8 (75%)
$5.72 (11.61%)
462
Buy
Since 09-Oct-2025
$65
$15.53 (31.39%)
$40
2 months 30 days ago
(09-Oct-2025)
22/24 (91.67%)
$15.49 (31.29%)
337
Buy
Since 06-Aug-2025
$63
$13.53 (27.35%)
$46
3 months 9 days ago
(30-Sep-2025)
3/4 (75%)
$15.21 (31.83%)
119
Buy
Since 24-May-2021
$44
$-5.47 (-11.06%)
$40
4 years 1 months 7 days ago
(01-Dec-2021)
14/15 (93.33%)
$13.15 (42.63%)
461
Buy
Since 10-May-2017
$35
$-14.47 (-29.25%)
$50
5 years 4 months 20 days ago
(19-Aug-2020)
4/4 (100%)
$11.6 (49.57%)
825
What is SUPN (Supernus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on SUPN (Supernus Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on SUPN (Supernus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on SUPN (Supernus Pharmaceuticals)?
Which analyst is the currently most bullish on SUPN (Supernus Pharmaceuticals)?
Which analyst is the currently most reserved on SUPN (Supernus Pharmaceuticals)?